Revenue
2018
2019
2020
2021
2022
2023
2024
2025
TELA Bio, Inc. (TELA)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $80.3M | $69.3M | $58.5M | $41.4M | $29.5M | $18.2M | $15.4M | $8.3M | $4.2M |
| Gross profit | $54.3M | $46.5M | $40.1M | $27.0M | $18.8M | $11.2M | $9.3M | $2.9M | $2.5M |
| Research & development | $9.2M | $8.8M | $9.6M | $8.9M | $6.7M | $4.3M | $4.2M | $4.3M | $5.8M |
| Operating expenses | $88.1M | $88.2M | $84.2M | $66.1M | $48.3M | $36.5M | $28.4M | $20.7M | $19.5M |
| Operating income | −$33.8M | −$34.1M | −$44.1M | −$39.0M | −$29.5M | −$25.3M | −$19.2M | −$17.8M | −$16.9M |
| Net income | −$38.8M | −$37.8M | −$46.7M | −$44.3M | −$33.3M | −$28.8M | −$22.4M | −$21.1M | −$21.3M |
| Basic EPSper diluted share | -$0.83 | -$1.33 | -$2.04 | -$2.72 | -$2.30 | -$2.23 | -$17.10 | -$101.41 | — |
| Diluted EPSper diluted share | -$0.83 | -$1.33 | -$2.04 | -$2.72 | -$2.30 | -$2.23 | -$17.10 | -$101.41 | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 17, 2025Form 4 | EW Healthcare Partners Fund 2-UGP, LLC +3TenPercentOwner,Other | BuyCommon Stock, par value $0.001 per share | 3.60M | $1.11 | $4.00M | 7.71M |
| Oct 24, 2024Form 4 | Cuca RobertoCOO and CFO | BuyCommon Stock | 64.4K | $2.25 | $145.0K | 155.4K |
| Oct 24, 2024Form 4 | Talmo PaulChief Technology Officer | BuyCommon Stock | 22.2K | $2.25 | $50.0K | 91.1K |
| Oct 24, 2024Form 4 | KOBLISH ANTONYChief Executive Officer | BuyCommon Stock | 88.9K | $2.25 | $200.0K | 458.9K |
| Oct 24, 2024Form 4 | Firestone Gregory A.Chief Commercial Officer | BuyCommon Stock | 6.7K | $2.25 | $15.0K | 57.3K |